Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P13497
UPID:
BMP1_HUMAN
Alternative names:
Mammalian tolloid protein; Procollagen C-proteinase
Alternative UPACC:
P13497; A8K6F5; B2RN46; D3DSR0; Q13292; Q13872; Q14874; Q99421; Q99422; Q99423; Q9UL38
Background:
Bone morphogenetic protein 1 (BMP1), also known as Mammalian tolloid protein or Procollagen C-proteinase, is pivotal in extracellular matrix formation, influencing bone and cartilage development, muscle growth, and tissue repair. It processes precursor proteins into mature enzymes or structural components, crucial for physiological functions.
Therapeutic significance:
BMP1's involvement in Osteogenesis imperfecta 13, characterized by bone fragility and recurrent fractures, underscores its therapeutic potential. Understanding BMP1's role could open doors to innovative treatments for bone disorders and improve quality of life for affected individuals.